Vagistat-1 vaginal ointment is now approved for OTC use

    Vagistat-1 vaginal ointment is now approved for OTC use. It's the first SINGLE-dose OTC treatment for vaginal yeast infections.

   Vagistat-1 (tioconazole) is comparable to using Terazol 3 (terconazole) or Monistat 7 (miconazole).

   Tioconazole levels persist for 3 to 5 days after one dose.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote